M.D. Sass, LLC
About M.D. Sass, LLC’s 13F portfolio
M.D. Sass, LLC is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , M.D. Sass, LLC reported $1.5B across 38 US-listed positions (). Its largest position is SCHEIN HENRY INC (HSIC) at 7.1% of the reported book, and its ten biggest holdings make up 54% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NASDAQ: HSIC SCHEIN HENRY INC | $85.69 +3.32% | 7.1% | 1.3M | $107.5M |
| 2 | NASDAQ: AMZN AMAZON COM INC | $267.74 +3.82% | 6.3% | 400K | $95.3M |
| 3 | NYSE: WMB WILLIAMS COS INC | $67.23 −0.34% | 5.4% | 1.1M | $80.9M |
| 4 | NYSE: CLH CLEAN HARBORS INC | $284.78 −1.29% | 5.4% | 271K | $80.8M |
| 5 | NYSE: AME AMETEK INC | $235.61 +0.33% | 5.3% | 333K | $80.7M |
| 6 | NYSE: PRMB PRIMO BRANDS CORPORATION | $22.96 −5.32% | 5.1% | 3.1M | $76.8M |
| 7 | NYSE: DGX QUEST DIAGNOSTICS INC | $259.69 +1.30% | 5.1% | 360K | $76.4M |
| 8 | NYSE: COF CAPITAL ONE FINL CORP | $184.30 −1.33% | 4.8% | 364K | $72.9M |
| 9 | — RBB FUND TRUST | — — | 4.8% | 2.9M | $72.2M |
| 10 | NYSE: SARO STANDARDAERO INC | $27.31 −0.26% | 4.6% | 2.3M | $70.2M |
| 11 | NYSE: SGI SOMNIGROUP INTERNATIONAL INC | $62.45 +7.39% | 4.3% | 836K | $65.6M |
| 12 | NASDAQ: CHRW C H ROBINSON WORLDWIDE IN | $137.47 −0.35% | 4.3% | 343K | $64.7M |
| 13 | NYSE: MLM MARTIN MARIETTA MATLS INC | $518.52 +2.82% | 4.1% | 108K | $62.0M |
| 14 | NASDAQ: ADI ANALOG DEVICES INC | $381.98 −0.44% | 4.1% | 155K | $61.5M |
| 15 | NYSE: WELL WELLTOWER INC | $247.25 +0.61% | 3.6% | 238K | $54.0M |
| 16 | NASDAQ: SNDK SANDISK CORP | $776.22 −2.64% | 3.3% | 22K | $49.9M |
| 17 | NYSE: SNX TD SYNNEX CORPORATION | $231.94 −0.60% | 3.3% | 186K | $49.8M |
| 18 | NYSE: KNX KNIGHT-SWIFT TRANSN HLDGS IN | $62.72 +0.67% | 3.2% | 616K | $47.9M |
| 19 | NYSE: FLS FLOWSERVE CORP | $81.46 +2.14% | 3.1% | 635K | $47.1M |
| 20 | NYSE: APG API GROUP CORP | $42.65 +0.61% | 2.5% | 893K | $37.8M |
| 21 | NASDAQ: ENTG ENTEGRIS INC | $143.78 +2.13% | 1.9% | 158K | $28.3M |
| 22 | NYSE: Q QNITY ELECTRONICS INC | $115.82 +1.16% | 1.7% | 162K | $26.4M |
| 23 | NASDAQ: MRVL MARVELL TECHNOLOGY INC | $145.54 −2.15% | 1.3% | 68K | $20.2M |
| 24 | NASDAQ: PANW PALO ALTO NETWORKS INC | $339.92 +9.90% | 0.8% | 36K | $12.2M |
| 25 | NYSE: APH AMPHENOL CORP | $76.33 −0.04% | 0.7% | 64K | $11.3M |
Showing 1–25 of 38 positions on this page reported in this 13F.
- Industrials29%
- Technology18%
- Healthcare13%
- Consumer Cyclical11%
- Energy5.4%
- Consumer Defensive5.1%
- Financial Services5.1%
- Basic Materials4.1%
- Real Estate3.6%
- Communication Services0.2%
- AddedHSICSCHEIN HENRY INC+1.1%$107.5M
- AddedAMZNAMAZON COM INC+51.4%$95.3M
- AddedCLHCLEAN HARBORS INC+7.1%$80.8M
- AddedDGXQUEST DIAGNOSTICS INC+20.4%$76.4M
- AddedCOFCAPITAL ONE FINL CORP+24.1%$72.9M
- AddedSAROSTANDARDAERO INC+9.2%$70.2M
- AddedSGISOMNIGROUP INTERNATIONAL INC+30.2%$65.6M
- AddedCHRWC H ROBINSON WORLDWIDE IN+52.0%$64.7M
- AddedMLMMARTIN MARIETTA MATLS INC+4.3%$62.0M
- NewADIANALOG DEVICES INC—$61.5M
- ReducedWMBWILLIAMS COS INC−7.4%$80.9M
- ReducedAMEAMETEK INC−7.9%$80.7M
- ReducedPRMBPRIMO BRANDS CORPORATION−7.1%$76.8M
- Reduced—RBB FUND TRUST−1.0%$72.2M
- ReducedWELLWELLTOWER INC−6.9%$54.0M
- ReducedAPGAPI GROUP CORP−35.5%$37.8M
- ReducedMRVLMARVELL TECHNOLOGY INC−11.6%$20.2M
- ReducedPANWPALO ALTO NETWORKS INC−29.0%$12.2M
- ReducedDHRDANAHER CORP DEL−79.2%$8.0M
- ReducedIWDISHARES TR−4.3%$7.6M
Reading M.D. Sass, LLC’s 13F portfolio
M.D. Sass, LLC’s $1.5B 13F book is spread across 38 reported positions and is concentrated toward its biggest ideas, with the top ten holdings at 54%. The largest positions carry real weight, so how those names perform matters a lot to the overall book. Its five largest positions are HSIC, AMZN, WMB, CLH and AME, led by SCHEIN HENRY INC (HSIC) at 7.1% of the portfolio. The heaviest sector exposure is Industrials (29%), then Technology (18%).
What M.D. Sass, LLC changed last quarter
Between 2026-03-31 and Q2 2026, M.D. Sass, LLC was roughly balanced between buying and selling: it opened 9 new positions and added to 12 more, while trimming 13 and closing 7 outright. Against a 38-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was SCHEIN HENRY INC (HSIC), and its biggest reduction was WILLIAMS COS INC (WMB).
What a 13F does and doesn’t reveal
A 13F captures only M.D. Sass, LLC’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names M.D. Sass, LLC is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. M.D. Sass, LLC's profile on this page is built directly from those filings.
How current is the 13F data on M.D. Sass, LLC's page?
It reflects M.D. Sass, LLC's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When M.D. Sass, LLC files its next quarterly report, this page refreshes automatically.
Can I see M.D. Sass, LLC's complete list of holdings?
This page highlights M.D. Sass, LLC's largest positions rather than all 38 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under M.D. Sass, LLC's filings.
Does a 13F show everything M.D. Sass, LLC owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of M.D. Sass, LLC's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why M.D. Sass, LLC made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

